Mepolizumab Showing Promise for High-Risk Eosophilic COPD Mepolizumab Showing Promise for High-Risk Eosophilic COPD

A biologic that targets interleukin-5 could reduce COPD exacerbations in patients with high blood eosinophil counts, new research shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news